Chan T C, Yu V M W, Luk J K H, Chu L W, Yuen J K Y, Chan F H W
Tuen-Ching Chan, Department of Medicine and Geriatrics, Fung Yiu King Hospital, 9 Sandy Bay Road, Pokfulam, Hong Kong, Email:
J Nutr Health Aging. 2022;26(3):247-251. doi: 10.1007/s12603-022-1747-2.
To assess the effectiveness of partially hydrolyzed guar gum (PHGG) in improving constipation and reducing the use of laxatives among long term care facility (LTCF) residents.
A single-center, prospective, randomized, placebo-controlled, single-blinded parallel-group trial from September 2021 to November 2021.
Four LTCF in Hong Kong.
Fifty-two LTCF residents with chronic constipation (mean age: 83.9±7.6 years, male 38%).
5g PHGG mixed with 200ml water per day for 4 weeks was given to intervention group participants. Control group received 200ml water for 4 weeks. Participants continued their usual as-needed laxative (lactulose, senna or dulcolax) on their own initiative.
Baseline measurements included age, gender, Charlson comorbidity index, Roackwood's Clinical Frailty Scale, body mass index and daily dietary fiber intake. Outcome measures were fecal characteristics assessed by Bristol Stool Form Scale, bowel opening frequency and laxative use frequency at baseline, first, second, third and fourth week of trial. Adverse events were measured. The study was registered on ClinicalTrial.gov; identifier: NCT05037565.
There was no significant difference in bowel frequency and stool characteristics between the treatment group and control group. However, there was a significantly lower frequency of lactulose, senna, and total laxative use in the treatment group compared with controls in the third and fourth week. There was no significant difference in adverse effects between the two groups.
This study showed that daily dietary fibre supplementation by using PHGG for 4 weeks in LTCF residents results in significantly less laxative use than placebo. It may be an effective way to reduce laxative dependence among older people living in LTCFs.
评估部分水解瓜尔胶(PHGG)对改善长期护理机构(LTCF)居民便秘及减少泻药使用的有效性。
2021年9月至2021年11月进行的单中心、前瞻性、随机、安慰剂对照、单盲平行组试验。
香港的四家长期护理机构。
52名患有慢性便秘的长期护理机构居民(平均年龄:83.9±7.6岁,男性占38%)。
干预组参与者每天服用5克PHGG与200毫升水混合的溶液,持续4周。对照组服用200毫升水,持续4周。参与者可自行根据需要继续使用常规泻药(乳果糖、番泻叶或杜密克)。
基线测量包括年龄、性别、查尔森合并症指数、罗克伍德临床衰弱量表、体重指数和每日膳食纤维摄入量。观察指标为在基线、试验第1、2、3和4周时,通过布里斯托大便形态量表评估的粪便特征、排便频率和泻药使用频率。记录不良事件。该研究已在ClinicalTrial.gov注册;标识符:NCT05037565。
治疗组和对照组在排便频率和粪便特征方面无显著差异。然而,在第3周和第4周时,治疗组使用乳果糖、番泻叶和总泻药的频率明显低于对照组。两组在不良反应方面无显著差异。
本研究表明,长期护理机构居民每日补充4周的PHGG膳食纤维,与安慰剂相比,泻药使用量显著减少。这可能是减少长期护理机构老年人泻药依赖的有效方法。